Other languages Champions Oncology, Inc.

Equities

CSBR

US15870P3073

Market Closed - Nasdaq Other stock markets 01:30:00 18/06/2024 am IST			5-day change	1st Jan Change
5.09 ^USD	+1.19%		+9.23%	-9.43%

04/06	Champions Oncology, Inc and Medicines Discovery Catapult Forge Partnership to Accelerate Radiopharmaceutical Therapeutics Development	CI
15/03	Tranche Update on Champions Oncology, Inc.'s Equity Buyback Plan announced on April 5, 2023.	CI

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Champions Oncology, Inc and Medicines Discovery Catapult Forge Partnership to Accelerate Radiopharmaceutical Therapeutics Development	04/06
Champions Oncology, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended January 31, 2024	13/03
Champions Oncology, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended October 31, 2023	13/12
MORNING BID AMERICAS-Disinflation station	12/12
Champions Oncology, Inc: Champions Oncology erhält für seinen europäischen Forschungsstandort eine ISO-9001:2015-Akkreditierung und ATS-Zertifizierung	02/11
Champions Oncology, Inc. Appoints Brady Davis as President	17/23/17
Champions Oncology, Inc. Reports Earnings Results for the First Quarter Ended July 31, 2023	14/23/14
Champions Oncology Enters Multiyear Deal With BioVolume to Better Evaluate Cancer Studies	01/23/01
Champions Oncology, Inc. Announces Multi-Year Agreement and Strategic Collaboration with BioVolume to Transform Reproducibility in Preclinical Oncology Efficacy Studies	01/23/01
Champions Oncology, Inc. Reports Earnings Results for the Full Year Ended April 30, 2023	25/23/25
Champions Oncology, Inc. Reports Earnings Results for the Fourth Quarter Ended April 30, 2023	25/23/25
Champions Oncology, Inc. announces an Equity Buyback for $5 million worth of its shares.	05/23/05
Champions Oncology, Inc. authorizes a Buyback Plan.	29/23/29
Champions Oncology, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended January 31, 2023	16/23/16
Champions Oncology, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended January 31, 2023	16/23/16
Champions Oncology, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended October 31, 2022	14/22/14
Champions Oncology, Inc. Provides Revenue Guidance for the Fiscal Year 2023	14/22/14
Champions Oncology Q2 EPS Declines, Revenue Rises to Record Level	14/22/14
Champions Oncology Fiscal Q1 Profit Slips, Revenue Rises	09/22/09
Champions Oncology, Inc. Reports Earnings Results for the First Quarter Ended July 31, 2022	09/22/09

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Champions Oncology, Inc.

Equities

CSBR

US15870P3073

Other languages

Filters